Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Clinical Rheumatology
Erschienen in: Clinical Rheumatology 2/2008

01.02.2008 | Review Article

The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis

verfasst von: Banu Kalpakcioglu, Kazim Şenel

Erschienen in: Clinical Rheumatology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis, a systemic autoimmune disease characterized by chronic inflammation of the synovial joints, ultimately leading to joint destruction and permanent disability, affecting 1% of the world population. Oxidative stress in rheumatoid inflammation, due to the fact that antioxidant systems are impaired in RA and caused by fee radicals, might have an essential role in etiology of RA. This review includes the interrelation of antioxidants against free radicals in RA patients. There is much evidence that antioxidant team that covers glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phopshate destroy reactive oxygen species and other free radicals through enzymatic as well as nonenzymatic means. The change in relative levels of antioxidants vis-à-vis free radical formation and level could be used as indicators for effective and earlier diagnosis of RA.
Literatur
1.
Glossop JR, Dawes PT, Mattey DL (2006) Association between cigarette smoking and release of tumour necrosis factor and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology 45:1223–1229PubMedCrossRef
2.
Martinez A, Valdivia A, Pascual-Salcedo D et al (2005) PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology 44:1263–1266PubMedCrossRef
3.
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis. Arthritis Rheuma 46:328–346CrossRef
4.
Evans P, Halliwell B (1999) Free radicals and hearing: cause, consequence, and criterie. Ann NY Acad Sci 884:19–40PubMedCrossRef
5.
Freeman BA, Crapo JD (1982) Free radicals and tissue injury. Lab Invest 47:412–426PubMed
6.
Lunec J, Blake D (1990) Oxygen free radicals: their relevance to disease processes. In: Cohen D, Lewis B, Albert KGMM (eds) The metabolic and moleculer basis of acquired disease. Balliere Tindall, London, pp 189–212
7.
Barbor DA, Harris SR (1994) Oxygen free radicals and antioxidants: a review. Am Pharm 34:26–35
8.
Greenwald RA (1991) Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum 20:219–240PubMedCrossRef
9.
Jasin HE (1997) Mechanism of tissue damage in rheumatoid arthritis. In: Koopman WJ (ed) Arthritis and allied conditions: textbook of rheumatology. Williams Wilkies, Baltimore, pp 1017–1036
10.
Imadaya A, Terasawa K, Tosa H (1988) Erythrocyte antioxydant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed
11.
Semble LE (1995) Rheumatoid arthritis. New approaches for its evaluation and management. Arch Phys Med Rehabil 76:190–200PubMedCrossRef
12.
Harris ED (1993) Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. WB Saunders, Philadelphia, pp 833–873
13.
Heliövaara M, Knekt P, Aho K et al (1994) Serum antioxidant and risk of rheumatoid arthritis. Ann Rheum Dis 53:51–53PubMed
14.
Blake DR, Hall ND, Treby DA et al (1981) Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci 61:483–486PubMed
15.
Mazetti I, Grigolo B, Borzi RM et al (1996) Serum copper/zinc superoxide dismutase levels in patients with rheumatoid arthritis. Int J Clin Lab Res 26:245–249CrossRef
16.
Shah ZA, Vohora SB (2002) Antioxidant/restorative effects of calcined gold preparations used in indian systems of medicine against global and focal models of ischaemia. Pharm & Toxicol 90:254–259CrossRef
17.
Rowley D, Gutteridge MC, Blake D et al (1984) Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 66:691–695PubMed
18.
Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355PubMedCrossRef
19.
Miyata T, Ishiguro N, Yasuda Y et al (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun 244:45–49PubMedCrossRef
20.
Chapman AP, Antoniw P, Spitali M et al (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17:780–783PubMedCrossRef
21.
22.
Karincaoglu Y, Batcioglu K, Erdem T et al (2005) The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol & Med 34:7–12CrossRef
23.
Gul M, Kutay FZ, Temocin S et al (2000) Cellular and clinical implications of glutathione. Indian J Exp Biol 38:625–634PubMed
24.
Taysi S, Polat F, Gul M et al (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef
25.
Kalavacherla US, Ishaq M, Rao URK et al (1994) Malondialdehyde as a sensitive marker of inflammation in patients with rheumatoid arthritis. J Assoc Phys India 42:775–776
26.
Bae SC, Kim SJ, Sung MK (2003) Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr 22:311–315PubMed
27.
Olivieri O, Girelli D, Trevisan MT et al (1991) Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patient with rheumatoid arthritis. J Rheumatol 18:1263–1264PubMed
28.
Jira W, Spiteller G, Richter A (1997) Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87:81–89PubMedCrossRef
29.
Pullar T, Zoma A, Capell HA et al (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol 26:202–206PubMedCrossRef
30.
Rae KJ, Mackay CN, McNeil CJ et al (1986) Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin. Ann Rheum Dis 45:839–846PubMedCrossRef
31.
Nivsarkar M (2000) Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Biochem Biophys Res Commun 270:714–716PubMedCrossRef
32.
Rister M, Bauermeister K (1982) Superoxid-Dismutase und Superoxid-Radikal-Freisetzung bei juveniler rheumatoider Arthritis. Klin Wochenschr 60:561–565PubMedCrossRef
33.
Ozkan Y, Yardım-Akaydın S, Sepici A et al (2007) Oxidative status in rheumatoid arthritis. Clin Rheumatol 26:64–68PubMedCrossRef
34.
Scudder PR, Al-Timimi D, McMurray W et al (1978) Serum copper and related variables in rheumatoid arthritis. Ann Rheum Dis 37:67–70PubMed
35.
Rasool M, Varalakshmi P (2007) Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam Clin Pharmacol 21:157–164PubMedCrossRef
36.
Braven J, Ansari N, Figgitt DP et al (1989) A comparison of glutathione reductase and glutathione peroxidase activities in patients with rheumatoid arthritis and healthy adults. Br J Rheumatol 8:212–215CrossRef
37.
Munthe E, Jellum E, Aaseth J et al (1986) Gold salts and selenium in the treatment of rheumatoid arthritis. In: Swaak AJG, Koster JF (eds) Free radicals in arthritis diseases. EURAGE, Rijswijk, The Netherlands, pp 121–128
38.
Islamov BI, Balabanova RM, Funtikov VA (2002) Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med 134:248–250PubMedCrossRef
39.
Tarp U (1986) Selenium and glutathione peroxidase in rheumatoid arthritis. In: Swaak AJG, Koster JF (eds) Free radicals in arthritis diseases. EURAGE, Rijswijk, The Netherlands, pp 69–73
40.
Mèzes M, Par A, Bartosceiwiecz G et al (1987) Vitamin E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol Hung 69:133–138PubMed
41.
Abella A, Clerc D, Chalas J et al (1987) Contration en superoxyde dismutase (cuivre et manganese) catalase et glutathion peroxydase dans les hematies, les plaquettes, et le plasma des sujets atteints de polyarthrite rhumatoide. Ann Biol Clin 45:152–155
42.
Vanella A, Scalia R, Terminella C et al (1987) Antioxidant enzymatic systems in erythrocytes from patients with rheumatoid arthritis. Pharmacol Res 15:1181–1188
43.
Vijayalakshmi T, Muthulakshmi V, Sachdanandam P (1997) Salubrious effect of Semecarpus anacardium against lipid peroxidative changes in adjuvant arthritis studied in rats. Mol Cell Biochem 175:65–69PubMedCrossRef
44.
Tarp U (1989) Selenium glutathione peroxidase in rheumatoid arthritis. Br J Rheumatol 29:158CrossRef
45.
Cimen MYB, Cimen OB, Kacmaz M et al (2000) Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19:275–277PubMedCrossRef
46.
Ramprasad VR, Shanthi P, Sachdanandam P (2005) Evaluation of antioxidant effect of Semecarpus anacardium Linn.nut extract on the components of immune system in adjuvants arthritis. Vasc Pharmacol 42:179–186CrossRef
47.
Kerimova AA, Atalay M, Yusifov EY et al (2000) Antioxidant enzymes; possible mechanism of gold compound treatment in rheumatoid arthritis. Pathophysiology 7:209–213PubMedCrossRef
48.
Kunau WH, Dommes V, Schulz H (1995) Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34:267–342PubMedCrossRef
49.
Benhamou PY, Moriscot C, Richard MJ et al (1998) Adenovirus-mediated catalase gene transcription reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41:1093–1100PubMedCrossRef
50.
El-Sohemy A, Cornelis MC, Park YW et al (2006) Catalase and PPARc2 genotype and risk of rheumatoid arthritis in Koreans. Rheumatol Int 26:388–392PubMedCrossRef
51.
Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115–124PubMedCrossRef
52.
Maurice M, Van der Voort E, Vilet A et al (1997) Chronic oxidative stress in rheumatoid arthritis: implication for T cell function. In: Montaguier L, Oliuier R, Pasquier C (eds) Oxidative stress in cancer, AIDS and neurodegenerative diseases. Marcel Dekker, New York, pp 537–546
53.
Bazzichi L, Ciompi ML, Betti L et al (2002) Impaired glutathione reductase activity and level of collogenase and elastase in synovial fluid in rheumatoid arthritis. Clin Exp Rheumatol 20:761–766PubMed
54.
Hassan MQ, Hadi RA, Al-Rawi ZS et al (2001) The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 21:69–73PubMedCrossRef
55.
Chow CK, Tappel AL (1972) An enzymatic protective mechanism against lipid peroxidation damage to lung of ozone exposed rats. Lipids 7:518–524PubMedCrossRef
56.
Herve CA, Wait R, Venables PJ (2003) Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology 42:986–988PubMedCrossRef
Metadaten
Titel
The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis
verfasst von
Banu Kalpakcioglu
Kazim Şenel
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 2/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0746-3

Weitere Artikel der Ausgabe 2/2008

Clinical Rheumatology 2/2008 Zur Ausgabe

Brief Report

Familial autoimmunity: maternal parent-of-origin effect in juvenile idiopathic arthritis

Case Report

Multiple peripheral arterial and aortic aneurysms in Behcet’s syndrome—a case report

Case Report

Severe invalidating pain syndrome associated with benznidazole therapy for Chagas’ disease

Original Article

Significance of anti-cell membrane-associated DNA (mDNA) antibodies in systemic lupus erythematosus

Case Report

A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma

Original Article

Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch–Schönlein purpura

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise